Carlisle Companies Incorporated Net Income per Employee (CSL), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Carlisle Companies Incorporated  (NYSE: CSL)
 

Carlisle Companies Incorporated Net Income per Employee

CSL's Quarterly Results, Trends, Rankings, Statistics
Carlisle Companies Incorporated's Income per employee fell in the first quarter 2026 on a trailing twelve month basis to $ 122,898, below the company average number of $91,052.
The Healthcare sector has seen employees of 11 other companies achieving higher income per employee. While Carlisle Companies Incorporated's total ranking has deteriorated compared to the previous quarter from 626 to 795.


What is Income per Employee Ratio?






CSL Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Net Income Change -10.89 % -21.74 % -12.32 % -64.09 % -25.48 %
Net Income per Employee (TTM) $ 122,898 125,542 131,542 136,644 214,034
CSL's Total Ranking # 795 # 626 # 381 # 968 # 745
Seq. Net Income Change 0.24 % -40.52 % -16.26 % 78.51 % -11.98 %


CSL Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 85
Overall Market # 795

Net Income per Employee Statistics
High Average Low
$ 239,763 $ 91,052 $ 31,847
(Sep 30 2024)   (Sep 30 2013)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Community Health Systems Inc   201,935.48 $ 626.000  Million 3,100 
Standard Biotools Inc   201,041.13 $ 78.205  Million 389 
Kiniksa Pharmaceuticals International Plc  199,612.02 $ 73.058  Million 366 
Xeris Biopharma Holdings Inc   199,000.00 $ 12.935  Million 65 
Lensar Inc   195,980.00 $ 29.397  Million 150 
Transmedics Group Inc   191,452.12 $ 171.924  Million 898 
Biogen Inc   182,920.00 $ 1,371.900  Million 7,500 
Zoetis Inc   182,275.86 $ 2,643.000  Million 14,500 
Apellis Pharmaceuticals Inc   180,336.94 $ 133.269  Million 739 
Therapeuticsmd Inc   179,000.00 $ 0.179  Million
Collegium Pharmaceutical Inc   177,184.40 $ 74.949  Million 423 
Intuitive Surgical Inc   176,188.24 $ 2,998.900  Million 17,021 
Johnson and Johnson  149,431.82 $ 21,040.000  Million 140,800 
Iradimed Corporation  142,232.36 $ 23.611  Million 166 
Puma Biotechnology Inc   136,223.46 $ 24.384  Million 179 
Resmed Inc   133,646.97 $ 1,519.566  Million 11,370 
Carlisle Companies Incorporated  122,898.31 $ 725.100  Million 5,900 
Merck and Co Inc   119,133.33 $ 8,935.000  Million 75,000 
Veracyte Inc   116,573.51 $ 88.013  Million 755 
Liquidia Corporation  103,263.89 $ 22.305  Million 216 
Pfizer Inc  100,466.67 $ 7,535.000  Million 75,000 
Idexx Laboratories Inc  99,566.64 $ 1,095.233  Million 11,000 
Inspire Medical Systems inc   98,376.59 $ 131.136  Million 1,333 
Globus Medical Inc   97,784.67 $ 586.708  Million 6,000 
Cryoport inc   97,205.96 $ 71.738  Million 738 
Lemaitre Vascular Inc   95,270.23 $ 62.402  Million 655 
Ani Pharmaceuticals Inc  94,997.94 $ 92.148  Million 970 
Dexcom Inc   83,819.82 $ 930.400  Million 11,100 
Biomarin Pharmaceutical Inc  83,434.34 $ 268.742  Million 3,221 
Progyny Inc   79,080.61 $ 67.693  Million 856 


Date modified: 2026-08-30T14:41:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.